CAT
Caterpillar Inc.
CAT has slightly lower modeled downside risk, despite its lower overall score.
SPXC
SPX Technologies, Inc.
SPXC has a slight edge over CAT overall, supported by stronger valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SPXC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
SPXC's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over SPXC in the historical PE scenario, which offers more potential upside but is not a forecast.
SPXC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $151 | — |
| Cheap | 18x | $109 | -28% |
| Current | 25x | $151 | — |
| Fair | 35x | $208 | +38% |
| Expensive | 70x | $412 | +174% |
Historical ranges are pointers, not guarantees.
SPXC's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over SPXC on the outlook, with more favorable profitability expectations.
SPXC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for SPXC, with profitability holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
SPXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.34 | +58% |
| Q3 2026 | $5.92 | +26% |
| Q2 2026 | $5.58 | +25% |
| Q1 2026 | $5.13 | +19% |
| Q4 2025 | $5.03 | +18% |
| Q3 2025 | $4.68 | +25% |
| Q2 2025 | $4.46 | +100% |
| Q1 2025 | $4.30 | +109% |
| Q4 2024 | $4.26 | +121% |
SPXC has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SPXC on profitability, with a higher operating margin.
SPXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $714.5M | +21% |
| Q2 2026 | $679M | +23% |
| Q1 2026 | $566.8M | +17% |
| Q4 2025 | $637.3M | +19% |
| Q3 2025 | $592.8M | +23% |
| Q2 2025 | $552.4M | +10% |
| Q1 2025 | $482.6M | +3.7% |
| Q4 2024 | $533.7M | +14% |
SPXC has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -0.2 points |
| Q2 2026 | 17% | +1.3 points |
| Q1 2026 | 15% | +1.7 points |
| Q4 2025 | 16% | -1.2 points |
| Q3 2025 | 16% | +0.1 points |
| Q2 2025 | 16% | +0.8 points |
| Q1 2025 | 14% | -0.1 points |
| Q4 2024 | 17% | +3.5 points |
SPXC's operating margin was 16% last quarter, about level with the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
SPXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $19.3M | -80% |
| Q2 2026 | $68.5M | +97% |
| Q1 2026 | $12.1M | +$28.5M |
| Q4 2025 | $126.7M | -19% |
| Q3 2025 | $96.1M | +121% |
| Q2 2025 | $34.8M | -26% |
| Q1 2025 | -$16.4M | -2833% |
| Q4 2024 | $156.7M | +32% |
SPXC generated $227M in free cash flow over the past year, down 16% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SPXC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SPXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -30K shares |
| 1 year | +3.5% | +1.7M shares |
| 3 years | +8.3% | +3.9M shares |
| 5 years | +8.6% | +4M shares |
| Available history | +13% | +5.7M shares |
SPXC has 51M diluted shares, up 3.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over SPXC on leverage, with a lower net debt burden relative to earnings.
SPXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.1x | Healthy |
SPXC's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SPXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 11.4 | Oversold |
SPXC's weekly RSI is 29 (oversold) and its Stochastic is 11 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over SPXC on valuation relative to its sector.
SPXC PE vs Industrials Sector
| Metric | SPXC | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 24x | 5.7% above |
| PE % | 33 | 58 | 25 pts below |
SPXC is trading at 25x earnings, in line with the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over SPXC on trend strength, trading above more of its moving averages.
SPXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $161.9 | 7% below |
| 20 week MA | $190.1 | 21% below |
| 50 week MA | $204.8 | 26% below |
| 100 week MA | $185.3 | 19% below |
| 200 week MA | $147.0 | 2.5% above |
SPXC has fallen below most of its moving averages, though it's still 2.5% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over SPXC on returns for 2026, with the stronger performance.
SPXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.6 | $53.9 | +6.5% |
| 2021 | $53.9 | $57.9 | +7.3% |
| 2022 | $57.9 | $65.3 | +13% |
| 2023 | $65.3 | $101.0 | +55% |
| 2024 | $101.0 | $146.0 | +45% |
| 2025 | $146.0 | $208.5 | +43% |
| 2026 YTD | $208.5 | $150.6 | -28% |
SPXC has finished every year since 2020 higher, and it's down 28% so far in 2026.